Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (116)
2025 (1325)
2024 (1331)
2023 (1277)
2022 (1392)
2021 (1425)
2020 (1224)
2019 (1083)
2018 (1143)
2017 (1036)
2016 (936)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (14812)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Hober S
JSON
CSV
XLSX
TXT
Family name
Hober
Given name
Sophia
Initials
S
ORCID
ORCID
0000-0003-0605-8417
Affiliations
Department of Protein Science, AlbaNova University Center, KTH–Royal Institute of Technology, Stockholm, Sweden.
16 publications
PubMed
DOI
Crossref
Engineered calcium-regulated affinity protein for efficient internalization and lysosomal toxin delivery.
Jönsson M
,
Möller M
,
Schierholz L
, ...,
Brismar H
,
Hober S
Proc. Natl. Acad. Sci. U.S.A.
122
(48) e2509081122 [2025-12-02; online 2025-11-25]
PubMed
DOI
Crossref
Deciphering the determinants of recombinant protein expression across the human secretome.
Masson HO,
Di Giusto P
, Kuo CC, ...,
Rockberg J
,
Lewis NE
Proc. Natl. Acad. Sci. U.S.A.
122
(41) e2506036122 [2025-10-14; online 2025-10-07]
PubMed
DOI
Crossref
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19.
Jernbom AF
,
Skoglund L
,
Pin E
, ...,
Månberg A
,
Nilsson P
Nat Commun
15
(1) 8941 [2024-10-17; online 2024-10-17]
PubMed
DOI
Crossref
The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity.
Abouzayed A, Borin J,
Lundmark F
, ..., Chernov V,
Orlova A
Diagnostics (Basel)
13
(9) - [2023-05-02; online 2023-05-02]
PubMed
DOI
Crossref
Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
Alkharaan H, Bayati S, Hellström C, ..., Pin E,
Sällberg Chen M
J. Infect. Dis.
227
(4) 603 [2023-02-14; online 2022-07-22]
PubMed
DOI
Crossref
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time.
Havervall S
, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C
Clin Transl Immunology
11
(4) e1388 [2022-04-18; online 2022-04-18]
PubMed
DOI
Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U,
Havervall S
, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines (Basel)
10
(3) - [2022-02-24; online 2022-02-24]
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.
Havervall S,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS ONE
17
(1) e0262169 [2022-01-12; online 2022-01-12]
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J. Intern. Med.
291
(1) 72-80 [2022-01-00; online 2021-09-27]
PubMed
DOI
Crossref
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM
, Havervall S, Laurén I, ..., Klingström J, Thålin C
PLoS ONE
16
(9) e0258041 [2021-09-30; online 2021-09-30]
Gustaf Christoffersson
SciLifeLab Fellow
PubMed
DOI
Crossref
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
Alkharaan H, Bayati S, Hellström C, ..., Pin E,
Sällberg Chen M
J. Infect. Dis.
224
(3) 407-414 [2021-08-02; online 2021-05-13]
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunology
10
(7) e1312 [2021-07-19; online 2021-07-19]
PubMed
DOI
Crossref
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
Dillner J, Elfström KM, Blomqvist J, ..., Arroyo Mühr LS, Lundgren KC
J. Infect. Dis.
224
(1) 14-20 [2021-07-02; online 2021-02-14]
PubMed
DOI
Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS
, Havervall S,
Månberg A
, ...,
Hober S
,
Thålin C
Nat Commun
11
(1) 5064 [2020-10-08; online 2020-10-08]
PubMed
DOI
Crossref
The human secretome.
Uhlén M
,
Karlsson MJ
,
Hober A
, ...,
Fagerberg L
,
Sivertsson Å
Sci Signal
12
(609) eaaz0274 [2019-11-26; online 2019-11-26]
Adil Mardinoglu
DDLS Fellow
Fredrik Edfors
SciLifeLab Fellow
PubMed
DOI
Crossref
A pathology atlas of the human cancer transcriptome.
Uhlen M
,
Zhang C
,
Lee S
, ...,
Mardinoglu A
,
Ponten F
Science (New York, N.Y.)
357
(6352) eaan2507 [2017-08-18; online 2017-08-19]
Adil Mardinoglu
Affiliated researcher
DDLS Fellow
Fredrik Edfors
Muhammad Arif
SciLifeLab Fellow
SciLifeLab Data Centre
Publications
9.5.1